DOXIL Trademark

Trademark Overview

On Thursday, November 21, 1991, a trademark application was filed for DOXIL with the United States Patent and Trademark Office. The USPTO has given the DOXIL trademark a serial number of 74223789. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, April 12, 2023. This trademark is owned by Liposome Technology, Inc.. The DOXIL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products and formulations for the treatment of cancer
doxil

General Information

Serial Number74223789
Word MarkDOXIL
Filing DateThursday, November 21, 1991
Status800 - REGISTERED AND RENEWED
Status DateWednesday, April 12, 2023
Registration Number1744235
Registration DateTuesday, January 5, 1993
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 13, 1992

Trademark Statements

Goods and Servicespharmaceutical products and formulations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateMonday, December 16, 1991
Primary Code005
First Use Anywhere DateFriday, November 1, 1991
First Use In Commerce DateFriday, November 1, 1991

Trademark Owner History

Party NameBAXTER INTERNATIONAL INC.
Party Type43 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDEERFIELD, IL 60015
Party NameBAXTER HEALTHCARE CORPORATION
Party Type42 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameALZA CORPORATION
Party Type41 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressVacaville, CA 95688
Party NameSEQUUS PHARMACEUTICALS, INC.
Party Type40 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025
Party NameLiposome Technology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameLiposome Technology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameLiposome Technology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Wednesday, April 12, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, April 12, 2023REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Wednesday, April 12, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, April 11, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, March 23, 2023POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, March 23, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 12, 2022TEAS SECTION 8 & 9 RECEIVED
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 5, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, March 27, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 13, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, November 13, 2012REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, November 13, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, November 9, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 9, 2012TEAS SECTION 8 & 9 RECEIVED
Tuesday, May 27, 2008CASE FILE IN TICRS
Thursday, March 20, 2003REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, March 20, 2003REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, December 18, 2002REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Wednesday, December 18, 2002PAPER RECEIVED
Saturday, June 12, 1999REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, December 28, 1998REGISTERED - SEC. 8 (6-YR) FILED
Tuesday, January 5, 1993REGISTERED-PRINCIPAL REGISTER
Tuesday, October 13, 1992PUBLISHED FOR OPPOSITION
Friday, September 11, 1992NOTICE OF PUBLICATION
Friday, July 10, 1992APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 19, 1992CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 25, 1992NON-FINAL ACTION MAILED
Tuesday, January 28, 1992ASSIGNED TO EXAMINER

Related Keywords

doxil cancer treatment formulations products pharmaceutical